EX-23.1 11 vrtx10k_2013-exhibit231.htm EX-23.1 VRTX 10K_2013-Exhibit 23.1


Exhibit 23.1
Consent of Independent Registered Public Accounting Firm

        We consent to the incorporation by reference in the Registration Statements (Form S-3 No. 333-186993 and Form S-8 Nos. 333-65666, 333-134482, 333-150945, 333-150946, 333-160442, 333-166803, 333-184784, 333-184787 and 333-188737) of Vertex Pharmaceuticals Incorporated of our reports dated February 11, 2014, with respect to the consolidated financial statements of Vertex Pharmaceuticals Incorporated and the effectiveness of internal control over financial reporting of Vertex Pharmaceuticals Incorporated, included in this Annual Report (Form 10-K) for the year ended December 31, 2013.

 
 
 
 
 
/s/ Ernst & Young LLP
Boston, Massachusetts
February 11, 2014